Cardio Diagnostics Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
-$0.77next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 16 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Quarterly2.7K
Cash and Cash Equivalents Quarterly7.1M
CMS Gapfill Payment Rate per Test Annually85,400.0%
Watch Items
- Medicare Coverage and Reimbursement ProgressTrigger: Securing broad Medicare coverage and local coverage determinations (LCDs)Action: Monitor SEC filings and corporate updates for coverage decisions by Medicare Administrative Contractors (MACs).
- Out-of-Network Commercial Billing CapabilityTrigger: Commencement of out-of-network commercial claims submission in Q2 2026Action: Verify execution of third-party billing partnerships and initial commercial payor cash collections.
- Effectiveness of Internal Disclosure ControlsTrigger: Remediation of material weaknesses in internal controls over financial reportingAction: Review Item 4 of upcoming Form 10-Q filings to confirm if management has successfully remediated control deficiencies.
Research as of 20 Jun 2026